Biomerica Inc. (BMRA) intrinsic value & 10-year financials
Biomerica Inc. (BMRA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 0.4% a year to $5.3M, with an average return on invested capital of -102.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.85
- Market cap
- $4.2M
- Revenue (FY2025)
- $5.3M
- Revenue growth (10-yr CAGR)
- 0.4%
- ROIC (10-yr avg)
- -102.5%
- Free cash flow (FY2025)
- —
BMRA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $5.3M | -$5.0M | -$2.16 | — | -96.7% | -219.2% |
| FY2024 | $5.4M | -$6.0M | -$0.36 | -$5.4M | -117.6% | -224.6% |
| FY2023 | $5.3M | -$7.1M | -$0.50 | -$5.5M | -135.3% | -231.7% |
| FY2022 | $18.9M | -$4.5M | -$0.36 | -$537.4K | -24.0% | -92.9% |
| FY2021 | $7.2M | -$6.5M | -$0.54 | -$5.4M | -90.6% | -96.9% |
| FY2020 | $6.7M | -$2.3M | -$0.23 | -$4.3M | -35.9% | -33.6% |
| FY2019 | $5.2M | -$2.4M | -$0.26 | -$2.3M | -46.4% | -58.1% |
| FY2018 | $5.6M | -$1.5M | -$0.17 | -$1.3M | -26.6% | -33.6% |
| FY2017 | $5.8M | -$908.6K | -$0.11 | -$818.9K | -16.5% | -18.7% |
| FY2016 | $5.1M | -$1.5M | -$0.20 | -$300.3K | -16.1% | -15.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BIOMERICA INC has demonstrated mature, steady growth, with revenue compounding at 0.4% annually over the past decade.
BIOMERICA INC has historically struggled to out-earn its cost of capital, averaging just -35.6% ROIC.
Over the decade, BIOMERICA INC shows that management has aggressively returned capital to shareholders by retiring 69.9% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BIOMERICA INC is modeled at 0.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-17.18 per share.